https://pmc.ncbi.nlm.nih.gov/articles/PMC9945324/
GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach - PMC
Obesity is a complex disease characterized by excessive fat accumulation which is caused by genetic, environmental and other factors. In recent years, there...
treatment of obesityreceptor agonists
https://pmc.ncbi.nlm.nih.gov/articles/PMC7064444/
Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol - PMC
Currently, an increasing number of diseases related to insulin resistance and obesity is an alarming problem worldwide. It is well-known that the above states...
treatment of obesityfor the
https://easo.org/framework-for-the-pharmacological-treatment-of-obesity-and-its-complications-from-the-european-association-for-the-study-of-obesity/
Framework for the Pharmacological Treatment of Obesity And its Complications from The European...
Jan 27, 2026 - EASO Medication Management Algorithm for Obesity: Personalising Obesity Medication Management Obesity is a chronic, relapsing disease with far-reaching...
treatment of obesityfor theand itsframeworkpharmacological